Evguenia M Alexandrova

3PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 01, 2021
Correction: p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer.

Christopher E Eyermann, Jinyu Li, Evguenia M Alexandrova

|May 23, 2021
ΔN63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer.

Christopher E Eyermann, Jinyu Li, Evguenia M Alexandrova

|Jan 27, 2021
The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer.

Christopher E Eyermann, John D Haley, Evguenia M Alexandrova

Pageof 1

Frequent Collaborators